IFNL4 genotype influences the rate of HIV-1 seroconversion in men who have sex with men
Individuals lacking interferon lambda 4 (IFNL4) protein due to a common null mutation (rs368234815) in the IFNL4 gene display higher resistance against several infections. The influence of IFNL4 on HIV-1 infection is still under discussion and conflicting results have been reported. This study inten...
- Autores:
 - 
                   Meza Barreto, Giovanna           
Galián, Fátima
Jaimes Bernal, Claudia Patricia
Márquez, Francisco J.
Sinangil, Faruk M.
Scagnolari, Carolina
Real, Luis Miguel
Forthal, Donald
Caruz, Antonio
 
- Tipo de recurso:
 - Article of investigation
 
- Fecha de publicación:
 - 2022
 
- Institución:
 - Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
 
- Repositorio:
 - Repositorio Institucional UDCA
 
- Idioma:
 -           eng          
 - OAI Identifier:
 - oai:repository.udca.edu.co:11158/4667
 - Acceso en línea:
 -           https://repository.udca.edu.co/handle/11158/4667
          
 - Palabra clave:
 -           Serodiagnóstico del SIDA          
Sida
 - Rights
 - openAccess
 - License
 - https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.es
 
| Summary: | Individuals lacking interferon lambda 4 (IFNL4) protein due to a common null mutation (rs368234815) in the IFNL4 gene display higher resistance against several infections. The influence of IFNL4 on HIV-1 infection is still under discussion and conflicting results have been reported. This study intended to corroborate or refute the association of the null allele of IFNL4 and HIV-1 predisposition in a cohort of men who have sex with men (MSM). IFNL4 null genotype was assessed on 619 HIV-1-seronegative MSM who were followed for 36 months during a trial of a prophylactic vaccine against HIV-1. Of those, 257 individuals seroconverted during this period. A logistic regression model was constructed including demographic and IFNL4 genotype. In addition, a meta-analysis using data from the current study and other European populations was conducted. The null IFNL4 genotypes were correlated with lower HIV-1 seroconversion (Adjusted OR = 0.4 [95%CI: 0.2–0.8], P = 0.008) and longer time to seroconversion (889 vs. 938 days, P= 0.01). These results were validated by a meta-analysis incorporating data from other European populations and the result yielded a significant association of the IFNL4 null genotype under a dominant model with a lower probability of HIV-1 infection (OR=0.4 [95% CI: 0.3-0.6]; P= 1.3 x 10E-5). © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. | 
|---|
